Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 23, 2026 08:01 ET | Source: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Securities Class Action Lawsuit Filed Against ImmunityBio, Inc. (IBRX)

ImmunityBio Shareholders Between January 19, 2026 and March 24, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
April 21, 2026 08:21 ET | Source: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ImmunityBio, Inc. (IBRX)

ImmunityBio Shareholders Between January 19, 2026 and March 24, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
April 16, 2026 08:38 ET | Source: Bernstein Liebhard LLP

IBRX INVESTOR ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ImmunityBio, Inc.

ImmunityBio Shareholders Between January 19, 2026 and March 24, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
April 14, 2026 08:14 ET | Source: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ImmunityBio, Inc. (IBRX)

ImmunityBio Shareholders Between January 19, 2026 and March 24, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
April 08, 2026 16:50 ET | Source: Hagens Berman Sobol Shapiro LLP

INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit– Hagens Berman

Investors who lost money in IBRX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
March 31, 2026 08:07 ET | Source: Bernstein Liebhard LLP

IMMUNITYBIO, INC. (IBRX) INVESTOR ALERT Investors With Large Losses in ImmunityBio, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

ImmunityBio Shareholders Between January 19, 2026 and March 24, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
August 28, 2023 13:31 ET | Source: Hagens Berman Sobol Shapiro LLP

IBRX FINAL DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys Before Aug. 29th Deadline in Securities Fraud Class Action

SAN FRANCISCO, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...
July 31, 2023 11:36 ET | Source: Hagens Berman Sobol Shapiro LLP

IBRX CLASS ACTION REMINDER: Hagens Berman Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending

SAN FRANCISCO, July 31, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...
July 24, 2023 12:01 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Notifies ImmunityBio (IBRX) Investors of Application Deadline in Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm’s Attorneys

SAN FRANCISCO, July 24, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23,...
July 17, 2023 11:56 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

SAN FRANCISCO, July 17, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...